Showing 1 - 20 results of 37 for search 'Katia Varani', query time: 0.04s Refine Results
  1. 1
    Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain

    Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain by Fabrizio Vincenzi, Silvia Pasquini, Pier Andrea Borea, Katia Varani

    Published 2020-11-01
    Get full text
    Article
  2. 2
    Adenosine and Inflammation: Here, There and Everywhere

    Adenosine and Inflammation: Here, There and Everywhere by Silvia Pasquini, Chiara Contri, Pier Andrea Borea, Fabrizio Vincenzi, Katia Varani

    Published 2021-07-01
    Get full text
    Article
  3. 3
    Design, synthesis and preliminary pharmacological evaluation of rigid analogues of the nicotinic agonist 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP)

    Design, synthesis and preliminary pharmacological evaluation of rigid analogues of the nicotinic agonist 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP) by Luca Guandalini, Elisabetta Martini, Fulvio Gualtieri, M. Novella Romanelli, Katia Varani

    Published 2004-04-01
    Get full text
    Article
  4. 4
    Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications

    Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications by Silvia Pasquini, Chiara Contri, Martina Cappello, Pier Andrea Borea, Katia Varani, Fabrizio Vincenzi

    Published 2022-10-01
    Get full text
    Article
  5. 5
    Piperazine- and Piperidine-Containing Thiazolo[5,4-<i>d</i>]pyrimidine Derivatives as New Potent and Selective Adenosine A<sub>2A</sub> Receptor Inverse Agonists

    Piperazine- and Piperidine-Containing Thiazolo[5,4-<i>d</i>]pyrimidine Derivatives as New Potent and Selective Adenosine A<sub>2A</sub> Receptor Inverse Agonists by Flavia Varano, Daniela Catarzi, Erica Vigiani, Fabrizio Vincenzi, Silvia Pasquini, Katia Varani, Vittoria Colotta

    Published 2020-07-01
    Get full text
    Article
  6. 6
    Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice

    Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice by Chiara Domenicale, Daniela Mercatelli, Federica Albanese, Salvatore Novello, Fabrizio Vincenzi, Katia Varani, Michele Morari

    Published 2022-04-01
    Get full text
    Article
  7. 7
    A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma

    A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma by Fabrizio Vincenzi, John Charles Rotondo, Silvia Pasquini, Francesco Di Virgilio, Katia Varani, Mauro Tognon

    Published 2021-10-01
    Get full text
    Article
  8. 8
    The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A<sub>1</sub>AR Positive Allosteric Modulation

    The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A<sub>1</sub>AR Positive Allosteric Modula... by Fabrizio Vincenzi, Silvia Pasquini, Stefania Gessi, Stefania Merighi, Romeo Romagnoli, Pier Andrea Borea, Katia Varani

    Published 2020-05-01
    Get full text
    Article
  9. 9
    Pulsed Electromagnetic Fields Stimulate HIF-1α-Independent VEGF Release in 1321N1 Human Astrocytes Protecting Neuron-like SH-SY5Y Cells from Oxygen-Glucose Deprivation

    Pulsed Electromagnetic Fields Stimulate HIF-1α-Independent VEGF Release in 1321N1 Human Astrocytes Protecting Neuron-like SH-SY5Y Cells from Oxygen-Glucose Deprivation by Fabrizio Vincenzi, Silvia Pasquini, Stefania Setti, Simona Salati, Ruggero Cadossi, Pier Andrea Borea, Katia Varani

    Published 2020-10-01
    Get full text
    Article
  10. 10
    Pulsed Electromagnetic Field Stimulation in Osteogenesis and Chondrogenesis: Signaling Pathways and Therapeutic Implications

    Pulsed Electromagnetic Field Stimulation in Osteogenesis and Chondrogenesis: Signaling Pathways and Therapeutic Implications by Katia Varani, Fabrizio Vincenzi, Silvia Pasquini, Irene Blo, Simona Salati, Matteo Cadossi, Monica De Mattei

    Published 2021-01-01
    Get full text
    Article
  11. 11
    Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets

    Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets by Silvia Pasquini, Chiara Contri, Stefania Merighi, Stefania Gessi, Pier Andrea Borea, Katia Varani, Fabrizio Vincenzi

    Published 2022-01-01
    Get full text
    Article
  12. 12
    A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?

    A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic? by Fabrizio Vincenzi, Silvia Pasquini, Enrica Battistello, Stefania Merighi, Stefania Gessi, Pier Andrea Borea, Katia Varani

    Published 2020-12-01
    Get full text
    Article
  13. 13
    Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition

    Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition by Alessandro Papa, Silvia Pasquini, Chiara Contri, Sandra Gemma, Giuseppe Campiani, Stefania Butini, Katia Varani, Fabrizio Vincenzi

    Published 2022-01-01
    Get full text
    Article
  14. 14
    Adenosinergic System Involvement in Ischemic Stroke Patients’ Lymphocytes

    Adenosinergic System Involvement in Ischemic Stroke Patients’ Lymphocytes by Silvia Pasquini, Fabrizio Vincenzi, Ilaria Casetta, Michele Laudisi, Stefania Merighi, Stefania Gessi, Pier Andrea Borea, Katia Varani

    Published 2020-04-01
    Get full text
    Article
  15. 15
    A<sub>2A</sub> Adenosine Receptor: A Possible Therapeutic Target for Alzheimer’s Disease by Regulating NLRP3 Inflammasome Activity?

    A<sub>2A</sub> Adenosine Receptor: A Possible Therapeutic Target for Alzheimer’s Disease by Regulating NLRP3 Inflammasome Activity? by Stefania Merighi, Manuela Nigro, Alessia Travagli, Silvia Pasquini, Pier Andrea Borea, Katia Varani, Fabrizio Vincenzi, Stefania Gessi

    Published 2022-05-01
    Get full text
    Article
  16. 16
    Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease

    Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease by Alessia Tarditi, Alessandra Camurri, Katia Varani, Pier Andrea Borea, Ben Woodman, Gillian Bates, Elena Cattaneo, Maria P. Abbracchio

    Published 2006-07-01
    Get full text
    Article
  17. 17
    COMBINED TARGETING OF FATTY ACID AMIDE HYDROLASE AND MELATONIN RECEPTORS PROMOTES NEUROPROTECTION AND STIMULATES INFLAMMATION RESOLUTION IN RATS

    COMBINED TARGETING OF FATTY ACID AMIDE HYDROLASE AND MELATONIN RECEPTORS PROMOTES NEUROPROTECTION AND STIMULATES INFLAMMATION RESOLUTION IN RATS by Mariarosaria Cammarota, Francesca Ferlenghi, Federica Vacondio, Fabrizio Vincenzi, Katia Varani, Annalida Bedini, Silvia Rivara, Marco Mor, Francesca Boscia

    Published 2023-10-01
    Get full text
    Article
  18. 18
    A<sub>2A</sub> Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease

    A<sub>2A</sub> Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease by Stefania Gessi, Tino Emanuele Poloni, Giulia Negro, Katia Varani, Silvia Pasquini, Fabrizio Vincenzi, Pier Andrea Borea, Stefania Merighi

    Published 2021-09-01
    Get full text
    Article
  19. 19
    Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy

    Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy by Mercedes Fernandez, Manuela Nigro, Alessia Travagli, Silvia Pasquini, Fabrizio Vincenzi, Katia Varani, Pier Andrea Borea, Stefania Merighi, Stefania Gessi

    Published 2023-10-01
    Get full text
    Article
  20. 20
    A2B and A3 Adenosine Receptors Modulate Vascular Endothelial Growth Factor and Interleukin-8 Expression in Human Melanoma Cells Treated with Etoposide and Doxorubicin

    A2B and A3 Adenosine Receptors Modulate Vascular Endothelial Growth Factor and Interleukin-8 Expression in Human Melanoma Cells Treated with Etoposide and Doxorubicin by Stefania Merighi, Carolina Simioni, Stefania Gessi, Katia Varani, Prisco Mirandola, Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Pier Andrea Borea

    Published 2009-10-01
    Get full text
    Article

Search Tools: